Iohexol IMAX

Medicinal product

(Invented) name

Iohexol IMAX

Active substance (s)

Joheksolis

Strength

647 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į arteriją, leisti į povoratinklinę ertmę

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V08AB02, Iohexol

Marketing authorisation holder

IMAX Diagnostic Imaging Limited, Airija

Date of authorisation

2014-12-23

Date of renewal

2021-05-17

Documents

3669 Iohexol IMAX PZ 2025 07 30.docx

3669 Pakuotės lapelis 2024 07 03.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PT/H/1099/002/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

1 ml yra	1 ml
Joheksolis	647 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
59231	73456	1073456	flakonas	50 ml N10		Receptinis	LT/1/14/3669/001	Tiekiama	-	-	No	-	-
59232	73457	1073457	flakonas	100 ml N10		Receptinis	LT/1/14/3669/002	Tiekiama	-	-	No	-	-
102875	88976	1088976	flakonas	200 ml N10		Receptinis	LT/1/14/3669/005	Netiekiama	-	-	No	-	-
102876	88977	1088977	flakonas	500 ml N10		Receptinis	LT/1/14/3669/006	Netiekiama	-	-	No	-	-
110465	96575	1096575	flakonas	500 ml N5		Receptinis	LT/1/14/3669/009	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-05-17	Perregistruotas
2014-12-23	Registruotas